nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GRIA3—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.0739	0.0739	CbGpPWpGaD
Lithium—GRIA3—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—CAMK2B—osteoarthritis	0.0469	0.0469	CbGpPWpGaD
Lithium—GRIA3—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0446	0.0446	CbGpPWpGaD
Lithium—GRIA3—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.0365	0.0365	CbGpPWpGaD
Lithium—GSK3B—Cellular response to heat stress—CAMK2B—osteoarthritis	0.0206	0.0206	CbGpPWpGaD
Lithium—GSK3A—IRE1alpha activates chaperones—HSPA5—osteoarthritis	0.0187	0.0187	CbGpPWpGaD
Lithium—GSK3B—Neural Crest Differentiation—SOX9—osteoarthritis	0.0184	0.0184	CbGpPWpGaD
Lithium—GSK3B—BMP receptor signaling—BMP2—osteoarthritis	0.0161	0.0161	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—COL10A1—osteoarthritis	0.0159	0.0159	CbGpPWpGaD
Lithium—GSK3B—Signaling by Hedgehog—IHH—osteoarthritis	0.015	0.015	CbGpPWpGaD
Lithium—GSK3B—IL-6 signaling pathway—TIMP1—osteoarthritis	0.0141	0.0141	CbGpPWpGaD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.0137	0.0137	CbGpPWpGaD
Lithium—GSK3A—Leptin signaling pathway—IL1RN—osteoarthritis	0.0125	0.0125	CbGpPWpGaD
Lithium—GSK3A—Unfolded Protein Response (UPR)—HSPA5—osteoarthritis	0.0125	0.0125	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—COMP—osteoarthritis	0.0116	0.0116	CbGpPWpGaD
Lithium—IMPA1—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.0115	0.0115	CbGpPWpGaD
Lithium—GRIA3—BDNF signaling pathway—BMP2—osteoarthritis	0.0114	0.0114	CbGpPWpGaD
Lithium—GSK3A—FOXM1 transcription factor network—ESR1—osteoarthritis	0.0112	0.0112	CbGpPWpGaD
Lithium—IMPA1—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.0107	0.0107	CbGpPWpGaD
Lithium—GRIA3—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0103	0.0103	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—COL9A2—osteoarthritis	0.0102	0.0102	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—BGLAP—osteoarthritis	0.00997	0.00997	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—COL9A1—osteoarthritis	0.00986	0.00986	CbGpPWpGaD
Lithium—GSK3B—Neural Crest Differentiation—COL2A1—osteoarthritis	0.00974	0.00974	CbGpPWpGaD
Lithium—GSK3B—Validated transcriptional targets of deltaNp63 isoforms—IL1A—osteoarthritis	0.00967	0.00967	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—MCF2L—osteoarthritis	0.00964	0.00964	CbGpPWpGaD
Lithium—GSK3A—FOXM1 transcription factor network—MMP2—osteoarthritis	0.00937	0.00937	CbGpPWpGaD
Lithium—GSK3B—Leptin signaling pathway—IL1RN—osteoarthritis	0.00924	0.00924	CbGpPWpGaD
Lithium—GSK3B—IL-6 signaling pathway—CRP—osteoarthritis	0.00868	0.00868	CbGpPWpGaD
Lithium—IMPA2—Metabolism—FMOD—osteoarthritis	0.00828	0.00828	CbGpPWpGaD
Lithium—GSK3B—LKB1 signaling events—ESR1—osteoarthritis	0.00811	0.00811	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—CAMK2B—osteoarthritis	0.00788	0.00788	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—BMP2—osteoarthritis	0.00775	0.00775	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—COL9A2—osteoarthritis	0.00751	0.00751	CbGpPWpGaD
Lithium—IMPA1—Metabolism—FMOD—osteoarthritis	0.00738	0.00738	CbGpPWpGaD
Lithium—GSK3A—Leptin signaling pathway—LEP—osteoarthritis	0.00736	0.00736	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—COL9A1—osteoarthritis	0.00729	0.00729	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—MCF2L—osteoarthritis	0.00712	0.00712	CbGpPWpGaD
Lithium—GSK3A—Leptin signaling pathway—ESR1—osteoarthritis	0.00703	0.00703	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PTGES—osteoarthritis	0.00675	0.00675	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—BMP2—osteoarthritis	0.00602	0.00602	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PTGES—osteoarthritis	0.00602	0.00602	CbGpPWpGaD
Lithium—GSK3B—Cardiac Progenitor Differentiation—IGF1—osteoarthritis	0.00594	0.00594	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—COL2A1—osteoarthritis	0.00588	0.00588	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—IGF1—osteoarthritis	0.00576	0.00576	CbGpPWpGaD
Lithium—GSK3B—Androgen receptor signaling pathway—SMAD3—osteoarthritis	0.00555	0.00555	CbGpPWpGaD
Lithium—GSK3B—Leptin signaling pathway—LEP—osteoarthritis	0.00544	0.00544	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—MMP1—osteoarthritis	0.00524	0.00524	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—MMP9—osteoarthritis	0.0052	0.0052	CbGpPWpGaD
Lithium—GSK3B—Leptin signaling pathway—ESR1—osteoarthritis	0.0052	0.0052	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL1A—osteoarthritis	0.00508	0.00508	CbGpPWpGaD
Lithium—GSK3B—Cell Cycle—SMAD3—osteoarthritis	0.00498	0.00498	CbGpPWpGaD
Lithium—GSK3B—LPA receptor mediated events—MMP2—osteoarthritis	0.00494	0.00494	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—SMAD3—osteoarthritis	0.00486	0.00486	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—ADAMTS13—osteoarthritis	0.0048	0.0048	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GSTO1—osteoarthritis	0.00475	0.00475	CbGpPWpGaD
Lithium—GSK3A—Unfolded Protein Response (UPR)—CXCL8—osteoarthritis	0.00474	0.00474	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—COL9A2—osteoarthritis	0.00473	0.00473	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—SMAD3—osteoarthritis	0.00472	0.00472	CbGpPWpGaD
Lithium—GSK3A—Leptin signaling pathway—IL1B—osteoarthritis	0.00469	0.00469	CbGpPWpGaD
Lithium—IMPA2—Metabolism—BGN—osteoarthritis	0.00461	0.00461	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—COL9A1—osteoarthritis	0.00459	0.00459	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—ADAMTS5—osteoarthritis	0.00452	0.00452	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—ADAMTS3—osteoarthritis	0.00452	0.00452	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—CAMK2B—osteoarthritis	0.00436	0.00436	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.00435	0.00435	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GSTO1—osteoarthritis	0.00424	0.00424	CbGpPWpGaD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—IGF1—osteoarthritis	0.00411	0.00411	CbGpPWpGaD
Lithium—GSK3B—LPA receptor mediated events—CXCL8—osteoarthritis	0.00411	0.00411	CbGpPWpGaD
Lithium—IMPA1—Metabolism—BGN—osteoarthritis	0.0041	0.0041	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.00402	0.00402	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—TNF—osteoarthritis	0.004	0.004	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—ESR1—osteoarthritis	0.004	0.004	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—FN1—osteoarthritis	0.00392	0.00392	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—ADAMTS4—osteoarthritis	0.00384	0.00384	CbGpPWpGaD
Lithium—GSK3B—LPA receptor mediated events—MMP9—osteoarthritis	0.00371	0.00371	CbGpPWpGaD
Lithium—GSK3B—Cardiac Progenitor Differentiation—TGFB1—osteoarthritis	0.00356	0.00356	CbGpPWpGaD
Lithium—GSK3B—Leptin signaling pathway—IL1B—osteoarthritis	0.00347	0.00347	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.00346	0.00346	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IGF1—osteoarthritis	0.00344	0.00344	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—COL9A2—osteoarthritis	0.00338	0.00338	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—CXCL8—osteoarthritis	0.00337	0.00337	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00333	0.00333	CbGpPWpGaD
Lithium—GSK3B—Alzheimers Disease—IL1B—osteoarthritis	0.00333	0.00333	CbGpPWpGaD
Lithium—GSK3A—Disease—FMOD—osteoarthritis	0.00332	0.00332	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—COL9A1—osteoarthritis	0.00328	0.00328	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—IL6—osteoarthritis	0.00323	0.00323	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—TNF—osteoarthritis	0.00323	0.00323	CbGpPWpGaD
Lithium—GSK3B—IL-6 signaling pathway—IL6—osteoarthritis	0.00317	0.00317	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CTSK—osteoarthritis	0.00316	0.00316	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—CXCL8—osteoarthritis	0.00307	0.00307	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CTSK—osteoarthritis	0.00303	0.00303	CbGpPWpGaD
Lithium—GSK3A—Disease—IHH—osteoarthritis	0.00296	0.00296	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—ESR1—osteoarthritis	0.00295	0.00295	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00288	0.00288	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—CXCL8—osteoarthritis	0.00276	0.00276	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—MMP9—osteoarthritis	0.00267	0.00267	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL1B—osteoarthritis	0.00265	0.00265	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—LEP—osteoarthritis	0.00247	0.00247	CbGpPWpGaD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.00246	0.00246	CbGpPWpGaD
Lithium—GSK3B—Disease—FMOD—osteoarthritis	0.00245	0.00245	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—FN1—osteoarthritis	0.00244	0.00244	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL1A—osteoarthritis	0.00243	0.00243	CbGpPWpGaD
Lithium—GSK3B—Alzheimers Disease—TNF—osteoarthritis	0.00241	0.00241	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—HSPA5—osteoarthritis	0.00241	0.00241	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00239	0.00239	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CTSK—osteoarthritis	0.00233	0.00233	CbGpPWpGaD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.0023	0.0023	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—TGFB1—osteoarthritis	0.00229	0.00229	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CTSK—osteoarthritis	0.00224	0.00224	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFBI—osteoarthritis	0.0022	0.0022	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—HSPA5—osteoarthritis	0.0022	0.0022	CbGpPWpGaD
Lithium—GSK3B—Disease—IHH—osteoarthritis	0.00218	0.00218	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—IGF1—osteoarthritis	0.00214	0.00214	CbGpPWpGaD
Lithium—GSK3B—Cell Cycle—TGFB1—osteoarthritis	0.00211	0.00211	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IHH—osteoarthritis	0.00207	0.00207	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MCF2L—osteoarthritis	0.00207	0.00207	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	0.00206	0.00206	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—TGFB1—osteoarthritis	0.002	0.002	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—MMP9—osteoarthritis	0.00197	0.00197	CbGpPWpGaD
Lithium—GSK3A—Disease—GSTO1—osteoarthritis	0.00191	0.00191	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL6—osteoarthritis	0.00189	0.00189	CbGpPWpGaD
Lithium—GSK3A—Disease—BGN—osteoarthritis	0.00185	0.00185	CbGpPWpGaD
Lithium—GSK3A—Immune System—CAMK2B—osteoarthritis	0.00184	0.00184	CbGpPWpGaD
Lithium—GSK3A—Immune System—CTSK—osteoarthritis	0.00184	0.00184	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HSPA5—osteoarthritis	0.00178	0.00178	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.00173	0.00173	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—IL6—osteoarthritis	0.00166	0.00166	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFBI—osteoarthritis	0.00163	0.00163	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00161	0.00161	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.00159	0.00159	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—IL6—osteoarthritis	0.00156	0.00156	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL6—osteoarthritis	0.00155	0.00155	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IHH—osteoarthritis	0.00153	0.00153	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MCF2L—osteoarthritis	0.00153	0.00153	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—COL9A2—osteoarthritis	0.00152	0.00152	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—IL6—osteoarthritis	0.00149	0.00149	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—IL6—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—IL6—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—COL9A1—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CRP—osteoarthritis	0.00147	0.00147	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—IL6—osteoarthritis	0.00147	0.00147	CbGpPWpGaD
Lithium—GSK3A—Immune System—HSPA5—osteoarthritis	0.00146	0.00146	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1RN—osteoarthritis	0.00142	0.00142	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—SMAD3—osteoarthritis	0.00141	0.00141	CbGpPWpGaD
Lithium—GSK3B—Disease—GSTO1—osteoarthritis	0.00141	0.00141	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—IL6—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—IL6—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—IL6—osteoarthritis	0.00137	0.00137	CbGpPWpGaD
Lithium—GSK3B—Disease—BGN—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Lithium—GSK3B—Immune System—CAMK2B—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Lithium—GSK3B—Immune System—CTSK—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—IL6—osteoarthritis	0.00135	0.00135	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—MMP2—osteoarthritis	0.00135	0.00135	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PTGS2—osteoarthritis	0.00132	0.00132	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—CXCL8—osteoarthritis	0.00132	0.00132	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—MMP1—osteoarthritis	0.0013	0.0013	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—LEP—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—IL6—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—LEP—osteoarthritis	0.0012	0.0012	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PTGS2—osteoarthritis	0.00118	0.00118	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.00117	0.00117	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—osteoarthritis	0.00115	0.00115	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—COL9A2—osteoarthritis	0.00112	0.00112	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—IL6—osteoarthritis	0.0011	0.0011	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—osteoarthritis	0.0011	0.0011	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—osteoarthritis	0.00109	0.00109	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—COL9A1—osteoarthritis	0.00109	0.00109	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CRP—osteoarthritis	0.00109	0.00109	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—osteoarthritis	0.00109	0.00109	CbGpPWpGaD
Lithium—GSK3B—Immune System—HSPA5—osteoarthritis	0.00108	0.00108	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1RN—osteoarthritis	0.00105	0.00105	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—IGF1—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1A—osteoarthritis	0.00102	0.00102	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—osteoarthritis	0.00102	0.00102	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—osteoarthritis	0.00102	0.00102	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.00102	0.00102	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—MMP9—osteoarthritis	0.00101	0.00101	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6—osteoarthritis	0.00101	0.00101	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—BMP2—osteoarthritis	0.00101	0.00101	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—MMP2—osteoarthritis	0.00101	0.00101	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.001	0.001	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6—osteoarthritis	0.001	0.001	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MMP2—osteoarthritis	0.000963	0.000963	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—osteoarthritis	0.000942	0.000942	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—osteoarthritis	0.000923	0.000923	CbGpPWpGaD
Lithium—GSK3A—Disease—SMAD3—osteoarthritis	0.000906	0.000906	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000905	0.000905	CbGpPWpGaD
Lithium—GSK3A—Immune System—CRP—osteoarthritis	0.000857	0.000857	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—CXCL8—osteoarthritis	0.000836	0.000836	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1A—osteoarthritis	0.000757	0.000757	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—BMP2—osteoarthritis	0.000747	0.000747	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—osteoarthritis	0.000742	0.000742	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MMP9—osteoarthritis	0.000724	0.000724	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MMP3—osteoarthritis	0.000701	0.000701	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—osteoarthritis	0.000696	0.000696	CbGpPWpGaD
Lithium—GSK3B—Disease—SMAD3—osteoarthritis	0.000669	0.000669	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SMAD3—osteoarthritis	0.000634	0.000634	CbGpPWpGaD
Lithium—GSK3B—Immune System—CRP—osteoarthritis	0.000633	0.000633	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—osteoarthritis	0.00063	0.00063	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—osteoarthritis	0.000597	0.000597	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—osteoarthritis	0.000557	0.000557	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LEP—osteoarthritis	0.000542	0.000542	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—osteoarthritis	0.000537	0.000537	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—osteoarthritis	0.000535	0.000535	CbGpPWpGaD
Lithium—GSK3A—Disease—PTGS2—osteoarthritis	0.00053	0.00053	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MMP3—osteoarthritis	0.000518	0.000518	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ESR1—osteoarthritis	0.000518	0.000518	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FN1—osteoarthritis	0.000511	0.000511	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SMAD3—osteoarthritis	0.000469	0.000469	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—osteoarthritis	0.00045	0.00045	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1—osteoarthritis	0.000448	0.000448	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LEP—osteoarthritis	0.000401	0.000401	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—osteoarthritis	0.000397	0.000397	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—osteoarthritis	0.000395	0.000395	CbGpPWpGaD
Lithium—GSK3B—Disease—PTGS2—osteoarthritis	0.000392	0.000392	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—osteoarthritis	0.000384	0.000384	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ESR1—osteoarthritis	0.000382	0.000382	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FN1—osteoarthritis	0.000378	0.000378	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL8—osteoarthritis	0.00036	0.00036	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1—osteoarthritis	0.000331	0.000331	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MMP9—osteoarthritis	0.000326	0.000326	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—osteoarthritis	0.000313	0.000313	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—osteoarthritis	0.000289	0.000289	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—osteoarthritis	0.000283	0.000283	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—osteoarthritis	0.000269	0.000269	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL8—osteoarthritis	0.000266	0.000266	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MMP9—osteoarthritis	0.000241	0.000241	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—osteoarthritis	0.000231	0.000231	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—osteoarthritis	0.000214	0.000214	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—osteoarthritis	0.000202	0.000202	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—osteoarthritis	0.000198	0.000198	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—osteoarthritis	0.00015	0.00015	CbGpPWpGaD
